Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aarey Drugs & PharmaceuticalsBOM:524412 +0.05%60 Days Inventory is 21.13 as of Mar. 2026, which is 10% above its 10-year median of 19.25. GuruFocus rates BOM:524412 with a GF Score™ of 60/100 and a GF Value™ of ₹58.31 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Aarey Drugs & Pharmaceuticals ranks better than 97.29% on this metric.
The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Days Inventory or its related term are showing as below:
BOM:524412'
s Days Inventory Range Over the Past 10 Years
Min: 3.47 Med: 19.25 Max: 34.94
Current: 33.77
During the past 13 years, Aarey Drugs & Pharmaceuticals's highest Days Inventory was 34.94. The lowest was 3.47. And the median was 19.25.
BOM:524412's Days Inventory is ranked better than 97.29% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:524412: 33.77
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aarey Drugs & Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 4.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aarey Drugs & Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.22.
Aarey Drugs & Pharmaceuticals (BOM:524412) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aarey Drugs & Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aarey Drugs & Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aarey Drugs & Pharmaceuticals Days Inventory Related Terms
Aarey Drugs & Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aarey Drugs & Pharmaceuticals Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aarey Drugs & Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aarey Drugs & Pharmaceuticals (BOM:524412) has a Days Inventory of 21.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aarey Drugs & Pharmaceuticals and its competitors. This is 10% above median its historical median of 19.25. Over the past decade, Aarey Drugs & Pharmaceuticals' Days Inventory has ranged from 3.47 to 34.94. According to the industry distribution chart, Aarey Drugs & Pharmaceuticals ranks #25 out of 923 companies in the Drug Manufacturers industry, placing it in the top 2.7%.
Is Aarey Drugs & Pharmaceuticals' Days Inventory too high?
Aarey Drugs & Pharmaceuticals' current Days Inventory of 21.13 is 10% above median its 10-year median of 19.25. Over the past 10 years, this metric has ranged from a low of 3.47 to a high of 34.94. The Drug Manufacturers industry median Days Inventory is 164.87. Aarey Drugs & Pharmaceuticals' value of 21.13 is 87.2% below this industry median. Based on the distribution chart, Aarey Drugs & Pharmaceuticals ranks #25 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Aarey Drugs & Pharmaceuticals has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aarey Drugs & Pharmaceuticals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aarey Drugs & Pharmaceuticals ranks #25 out of 923 companies for Days Inventory. This places Aarey Drugs & Pharmaceuticals in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Aarey Drugs & Pharmaceuticals' value of 21.13 is 87.2% below this benchmark. Historically, Aarey Drugs & Pharmaceuticals' own Days Inventory has ranged from 3.47 to 34.94 over the past decade. While the company's 10-year median is 19.25 vs. the industry median of 164.87, Aarey Drugs & Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aarey Drugs & Pharmaceuticals's current Days Inventory of 21.13 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aarey Drugs & Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aarey Drugs & Pharmaceuticals's current Days Inventory is 21.13, which is 10% above median its own 10-year median of 19.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarey Drugs & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals (BOM:524412) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹58.31, compared to a current price of ₹83.94 — trading 44% above its estimated fair value. The current Days Inventory is 21.13, which is 10% above median its 10-year median of 19.25 and 87.2% below the Drug Manufacturers industry median of 164.87. Aarey Drugs & Pharmaceuticals' overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aarey Drugs & Pharmaceuticals (BOM:524412), the current Days Inventory is 21.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aarey Drugs & Pharmaceuticals (BOM:524412) Overvalued in 2026?
Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹83.94 is trading 44% above its estimated GF Value™ of ₹58.31.
GuruFocus considers Aarey Drugs & Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for BOM:524412:
Days Inventory: 21.13 (10% above median its 10-year median of 19.25)
GF Value™: ₹58.31 vs. price of ₹83.94 (44% above fair value)
Industry Position: 87.2% below the Drug Manufacturers median (#25 of 923)
No single metric tells the full story. See the BOM:524412 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, and BMD among others. The company principally carries out its business operations in India.
60GF Score
Get the complete analysis for BOM:524412
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524412 has been successfully added to your 
